- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02501187
Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair
April 11, 2018 updated by: Maya Eiger, Rabin Medical Center
Comparison Between Three Different Surgeries for Blepharoptosis Repair and Their Impact on Dry Eye Status
Blepharoptosis, inferodisplacement of the upper eyelid, can be congenital or acquired.
Acquired Blepharoptosis is usually aponeurotic, due to stretching or disinsertion of the levator aponeurosis.
Treatment is surgical and can be performed by three common procedures - Levator advancement, Müller's muscle-conjunctival resection procedure and White line advancement.
A number of reports inspected the possibility that Blepharoptosis repair procedures may cause deterioration in dry eye status.
The investigators would like to assess whether there is a difference between the different procedures in their influence on dry eye status.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maya Eiger, MD
- Phone Number: +972-3-9376107
- Email: mayae2@clalit.org.il
Study Locations
-
-
-
Petach Tikva, Israel
- Recruiting
- Ophthalmology clinics, Rabin Medical Center
-
Contact:
- Maya Eiger, MD
- Phone Number: +972-3-9376017
- Email: mayae2@clalit.org.il
-
Principal Investigator:
- Maya Eiger, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ptosis which indicate surgical repair
- The ptosis must be suitable for repair in any of the procedures
Exclusion Criteria:
- Systemic disease which may cause ocular surface disease (eg Sjogren disease)
- Previous orbital or eyelid surgery
- Significantly dry eyes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients operated for ptosis by levator advancement
patients undergoing surgical repair for aponeurotic ptosis by the procedure- levator advancement.
|
A transcutaneous procedure in which the Levator palpebrae aponeurosis is advanced and attached to the tarsus.
|
Experimental: Patients operated for ptosis by white line advancement
patients undergoing surgical repair for aponeurotic ptosis by the procedure- white line advancement
|
A transconjunctival procedure in which the Levator palpebrae aponeurosis is advanced and attached to the tarsus.
|
Experimental: Patients operated for ptosis by Müller resection
patients undergoing surgical repair for aponeurotic ptosis by the procedure- Müller's muscle-conjunctival resection.
|
A transconjunctival procedure in which part of the muller muscle and conjunctiva are resected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnosis of objective or subjective deterioration in dry eye status
Time Frame: 6 months
|
Dry eye status will be measured by a composite of tests, including Ocular surface disease index (OSDI) questionnaire (which indicates subjective status), and a number of objective tests - Shirmer test, Flurocein dye, Lissamine green dye and tear breakup time
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ptosis repair procedure success
Time Frame: 6 months
|
Success will be assessed by comparison of margin reflex distance1 (MRD1) measurement before and after surgery
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 8, 2015
Primary Completion (Anticipated)
July 1, 2020
Study Completion (Anticipated)
July 1, 2020
Study Registration Dates
First Submitted
July 12, 2015
First Submitted That Met QC Criteria
July 15, 2015
First Posted (Estimate)
July 17, 2015
Study Record Updates
Last Update Posted (Actual)
April 13, 2018
Last Update Submitted That Met QC Criteria
April 11, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ptosis-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blepharoptosis
-
RVL Pharmaceuticals, Inc.CompletedAcquired BlepharoptosisUnited States
-
Levation Pharma, Ltd.Completed
-
Skelmet IncMassachusetts Eye and Ear InfirmaryCompleted
-
RVL Pharmaceuticals, Inc.CompletedBlepharoptosisUnited States
-
CHU de Quebec-Universite LavalCompleted
-
Cairo UniversityCompleted
-
University of MiamiCompleted
-
RVL Pharmaceuticals, Inc.Completed
Clinical Trials on Levator advancement
-
Heba Hamdy Ibrahim MohammedCompletedCongenital PtosisEgypt
-
Sohag UniversityNot yet recruitingCongenital PtosisEgypt
-
Sahlgrenska University Hospital, SwedenSwedish Cancer FoundationCompleted
-
Menoufia UniversityUnknown
-
Al-Azhar UniversityCompleted
-
Massachusetts Eye and Ear InfirmaryActive, not recruitingStroke | Myasthenia Gravis | Traumatic Brain Injury | Ptosis, Eyelid | BlepharoptosisUnited States
-
Hospital Universitario San IgnacioCompleted
-
Riphah International UniversityRecruiting